Case Study: Sante International reduces airborne pathogens with Novaerus technology from WellAir

Sante International reduces airborne bacteria by 89% with WellAir

Sante International, a healthcare distributor in Romania, faced the challenge of convincing its skeptical hospital customers that WellAir's Novaerus technology was a significant improvement over dated infection control solutions like HEPA and UV. Their customers were reluctant to believe the new units could offer a more efficient and complete solution.

WellAir implemented a three-month air sampling trial at a major hospital using its Protect 800 and Protect 200 units. The results showed an 89% reduction in airborne bacteria, an 87% reduction in airborne fungi, and nearly 100% reduction in airborne Staphylococcus. This measurable proof, along with qualitative benefits like minimal maintenance and safety, convinced the hospital and provided Sante International with the evidence needed to demonstrate value to other customers.

Sante International